Subsequently, the TCIA database was used to evaluate the relationship between PD-L1 expression and the response to immune checkpoint inhibitors (CTLA-4 and PD-1 blockers) in FTC patients. This evidence concerns the gene CTLA4 and thyroid cancer, nonmedullary, 2.